Latest Share Chat

REMOVE ADS

CLL.L Regulatory News (CLL)

CLL.L Information

There is currently no data for CLL

REMOVE ADS

Director/PDMR Shareholding

20 Jun 2019 16:29

RNS Number : 9465C

Cello Health PLC

20 June 2019

Cello Health plc

("Cello" or the "Group")

Director/PDMR Shareholding

The Group announces that, on 20 June 2019, certain directors and persons discharging managerial responsibilities (PDMRs) of the Group exercised 10p options over a total of 965,000 ordinary shares of 10 pence each ("Ordinary Shares") pursuant to the Group's PSP Option Scheme 2010, and subsequently sold 600,100 Ordinary Shares at a price of 126.6 pence per Ordinary Share. Details of the option exercises, share sales and resultant shareholdings are set out below:

Name	Title	Options exercised	Ordinary Sharessold	Resultant holding	Percentage of issued share capital
Mark Scott	Chief Executive	450,000	265,500	1,649,975	1.5%
Mark Bentley	Finance Director	220,000	129,800	532,718	0.5%
Stephen Highley	COO	220,000	129,800	2,226,304	2.1%
Andy Brown	Deputy Finance Director	75,000	75,000	6,160	0.01%

The new Ordinary Shares have been issued pursuant to the Group's existing block listing and, as at 20 June 2019, Cello's issued share capital comprises 106,530,309 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The Group's total number of voting rights is therefore 106,077,309 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

This announcement contains inside information.

Enquiries:

Cello Health plc	020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Finance Director

Cenkos Securities plc	0207 397 8900
Mark Connelly Harry Hargreaves

Notes to Editors

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.

For further information, please visit: https://cellohealthplc.com

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Scott
2	Reason for the notification
a)	Position/status	Chief Executive
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Exercise of options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			10 pence	450,000

d)	Aggregated information
	- Aggregated volume	450,000
	- Price	£45,000.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	Outside of a trading venue (XOFF)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Scott
2	Reason for the notification
a)	Position/status	Chief Executive
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Sale of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			126.6 pence	265,000

d)	Aggregated information
	- Aggregated volume	265,000
	- Price	£336,123.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	AIMX

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Bentley
2	Reason for the notification
a)	Position/status	Finance Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Exercise of options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			10 pence	220,000

d)	Aggregated information
	- Aggregated volume	220,000
	- Price	£22,000.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	Outside of a trading venue (XOFF)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Bentley
2	Reason for the notification
a)	Position/status	Finance Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Sale of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			126.6 pence	129,800

d)	Aggregated information
	- Aggregated volume	129,800
	- Price	£164,326.80
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	AIMX

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stephen Highley
2	Reason for the notification
a)	Position/status	COO
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Exercise of options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			10 pence	220,000

d)	Aggregated information
	- Aggregated volume	220,000
	- Price	£22,000.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	Outside of a trading venue (XOFF)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stephen Highley
2	Reason for the notification
a)	Position/status	COO
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Sale of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			126.6 pence	129,800

d)	Aggregated information
	- Aggregated volume	129,800
	- Price	£164,326.80
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	AIMX

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Andy Brown
2	Reason for the notification
a)	Position/status	Deputy Finance Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Exercise of options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			10 pence	75,000

d)	Aggregated information
	- Aggregated volume	75,000
	- Price	£7,500.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	Outside of a trading venue (XOFF)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Andy Brown
2	Reason for the notification
a)	Position/status	Group FC and CFO
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cello Health plc
b)	LEI	2138004TZYGZLWQP7N64
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 10 pence each
	Identification code	ISIN: GB00B0310763
b)	Nature of the transaction	Sale of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			126.6 pence	75,000

d)	Aggregated information
	- Aggregated volume	75,000
	- Price	£94,950.00
e)	Date of the transaction	20 June 2019
f)	Place of the transaction	AIMX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHCKKDBPBKDFAB

Date		Source	Headline
29th Jun 2007	7:01 am	RNS	Director/PDMR Shareholding
28th Jun 2007	7:01 am	RNS	Directorate Change
8th Jun 2007	7:01 am	RNS	Acquisition
22nd May 2007	1:00 pm	RNS	AGM Statement
16th May 2007	9:43 am	RNS	Share Option Grants
1st May 2007	4:15 pm	RNS	Annual Report and Accounts
1st May 2007	4:13 pm	RNS	Share Option Grants
27th Apr 2007	12:41 pm	RNS	Director/PDMR Shareholding
26th Apr 2007	7:01 am	RNS	Investment
10th Apr 2007	9:44 am	RNS	Total voting rights update
2nd Apr 2007	3:48 pm	RNS	Director/PDMR Shareholding
30th Mar 2007	7:01 am	RNS	Acquisition
29th Mar 2007	2:07 pm	RNS	Holding(s) in Company
20th Mar 2007	7:01 am	RNS	Final Results
9th Mar 2007	1:18 pm	RNS	Holding(s) in Company
28th Feb 2007	4:53 pm	RNS	Holding(s) in Company
19th Feb 2007	11:14 am	RNS	Notice of Results
2nd Feb 2007	3:05 pm	RNS	Total Voting Rights
29th Jan 2007	7:01 am	RNS	Acquisition
19th Jan 2007	3:19 pm	RNS	Holding(s) in Company
11th Jan 2007	7:01 am	RNS	Pre Close Trading Statement
15th Dec 2006	9:01 am	RNS	Director/PDMR Shareholding
12th Dec 2006	9:00 am	RNS	Total Voting Rights
30th Nov 2006	3:56 pm	RNS	Holding(s) in Company
13th Nov 2006	12:48 pm	RNS	Analyst/Investor Presentation
5th Oct 2006	5:10 pm	RNS	Notifiable Interest
4th Oct 2006	3:53 pm	RNS	Holding(s) in Company
26th Sep 2006	7:03 am	RNS	Acquisition
11th Sep 2006	3:58 pm	RNS	Holding(s) in Company
5th Sep 2006	7:02 am	RNS	Investment in Digital Agency
5th Sep 2006	7:02 am	RNS	Interim Results
17th Aug 2006	9:54 am	RNS	Notice of Results
26th Jul 2006	2:17 pm	RNS	Additional Listing
3rd Jul 2006	11:53 am	RNS	Additional Listing
3rd Jul 2006	7:01 am	RNS	Pre Close Trading Statement
3rd Jul 2006	7:01 am	RNS	Controlling Stake
26th Jun 2006	3:23 pm	RNS	Invest in brand consulting op
26th Jun 2006	7:19 am	RNS	Acquisition
21st Jun 2006	12:15 pm	RNS	Annual Report and Accounts
19th Jun 2006	3:22 pm	RNS	Major Interest in Shares
23rd May 2006	12:58 pm	RNS	AGM Statement
27th Mar 2006	5:46 pm	RNS	Major Interest in Shares
27th Mar 2006	5:05 pm	RNS	Major Interests in Shares
21st Mar 2006	3:39 pm	RNS	Holding(s) in Company
16th Mar 2006	7:00 am	RNS	Performance Share Option Plan
15th Mar 2006	7:01 am	RNS	Director/PDMR Shareholding
14th Mar 2006	7:05 am	RNS	Share Option Plan
14th Mar 2006	7:02 am	RNS	Final Results
20th Feb 2006	5:19 pm	RNS	Notice of Results
25th Jan 2006	3:11 pm	RNS	Holding(s) in Company

Latest Share Chat

CLL.L Regulatory News (CLL)

Director/PDMR Shareholding

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending